Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Sebastian, S, Lambe, T
Format:	Journal article
Udgivet:	MDPI 2018

Lignende værker

Clinical Advances in Viral-Vectored Influenza Vaccines
af: Sarah Sebastian, et al.
Udgivet: (2018-05-01)

Viral vector vaccines
af: McCann, N, et al.
Udgivet: (2022)

Clinical development of viral vectored vaccines against MERS-COV
af: Ewer, K, et al.
Udgivet: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
af: D. A. Mezhenskaia, et al.
Udgivet: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
af: Bissett, C, et al.
Udgivet: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
af: Ewer (nee Russell), K, et al.
Udgivet: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
af: Cameron Bissett, et al.
Udgivet: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
af: Arunkumar, G, et al.
Udgivet: (2019)

Research advances in replication-deficient viral vector vaccines
af: Junna Wang, et al.
Udgivet: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
af: McMahon, M, et al.
Udgivet: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
af: Antrobus, R
Udgivet: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
af: Tully, C, et al.
Udgivet: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
af: Tully, C
Udgivet: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
af: Mullin, J, et al.
Udgivet: (2014)

Development of viral vectors for passive immunisation against influenza
af: Tan, TK
Udgivet: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
af: Marta Ulaszewska, et al.
Udgivet: (2023-01-01)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
af: Irina Isakova-Sivak, et al.
Udgivet: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
af: Antrobus, R, et al.
Udgivet: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
af: Antrobus, R, et al.
Udgivet: (2014)

Adenoviral vectors as novel vaccines for influenza.
af: Coughlan, L, et al.
Udgivet: (2015)

Virus-Vectored Influenza Virus Vaccines
af: Ralph A. Tripp, et al.
Udgivet: (2014-08-01)

Viral vectors for malaria vaccine development.
af: Li, S, et al.
Udgivet: (2007)

The use of viral vectors in vaccine development
af: Tatianna Travieso, et al.
Udgivet: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
af: Kenneth Lundstrom
Udgivet: (2016-11-01)

Developments in Viral Vector-Based Vaccines
af: Takehiro Ura, et al.
Udgivet: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
af: Ewer (nee Russell), K, et al.
Udgivet: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
af: Kapulu, MC
Udgivet: (2014)

Recombinant influenza A viruses as vaccine vectors
af: Thomas Gerlach, et al.
Udgivet: (2019-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
af: Katie Ewer, et al.
Udgivet: (2017-12-01)

Viral vectors as vaccine platforms: Deployment in sight
af: Rollier, C, et al.
Udgivet: (2011)

Novel viral vector vaccines for tropical infections
af: Rampling, T
Udgivet: (2017)

Viral vectors as vaccine platforms: deployment in sight.
af: Rollier, C, et al.
Udgivet: (2011)

Viral Vectors for COVID-19 Vaccine Development
af: Kenneth Lundstrom
Udgivet: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
af: Luis Jiménez-Cabello, et al.
Udgivet: (2020-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
af: Sushmita Kumari, et al.
Udgivet: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
af: Jianfeng Zhang
Udgivet: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
af: Shintaro Shichinohe, et al.
Udgivet: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
af: L. M. Khantimirova, et al.
Udgivet: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
af: McAuliffe, J
Udgivet: (2020)

Baculovirus expression vector system for production of viral vaccines /
af: 300419 Vlak, J. M., et al.